期刊文献+

15-PGDH在食管癌中的表达

The expression of 15-PGDH in esophageal carcinoma
下载PDF
导出
摘要 目的研究NAD+依赖性15-羟基前列腺素脱氢酶(15-PGDH)在食管癌组织及癌旁6 cm处非肿瘤对照组织中的表达,探讨15-PGDH在食管癌中的表达情况及其与食管癌的关系。方法本实验采用免疫组化SP法检测食管癌组织和癌旁6 cm处非肿瘤对照组织中15-PGDH的表达情况。结果免疫组化结果提示:40例食管癌组织中有5例(12.5%)15-PGDH呈强阳性染色,8例(20.0%)15-PGDH呈弱阳性染色,27例(67.5%)15-PGDH表达缺失;40例癌旁6 cm处对照组织中,13例(32.5%)15-PGDH呈强阳性染色,25例(62.5%)15-PGDH呈弱阳性染色,2例(5.0%)15-PGDH染色阴性(P<0.05)。15-PGDH在食管癌组织(32.5%)的阳性表达率显著低于癌旁6 cm处非肿瘤对照组织(95.0%)的阳性表达率,15-PGDH的表达差异有统计学意义(P<0.05)。15-PGDH蛋白表达与食管癌患者的性别、年龄、分化程度无关(P>0.05)。15-PGDH蛋白表达与食管癌患者有无淋巴结转移有关(P<0.05)。结论 15-PGDH在食管癌组织中表达缺失或减少,15-PGDH可能是食管癌发生发展中的重要抑制因子。 Objective To study the expression of NAD^+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in the tissue of esophageal carcinoma and normal esophageal mucosa next to the carcinoma,and investigate its possible implication.Methods In the tissue of normal esophageal mucosa next to the carcinoma (40 cases),esophageal carcinoma (40 cases),the protein expression of 15-PGDH was detected by immunohistochemistry SP method.Results Immunohistochemistry:among 40 cases of esophageal carcinoma,there was no expression of 15-PGDH in 27 cases (67.5%),8 cases (20.0%) showed a weak positive staining of 15-PGDH,5 cases (12.5%) of 15-PGDH was strongly positive staining; among 40 cases of normal esophageal mucosa next to the carcinoma,13 cases (32.5%) of 15-PGDH was strongly positive staining,25 cases (62.5%) showed a weak positive staining of 15-PGDH,there was no expression of 15-PGDH in 2 cases (5.0%) (P 〈 0.05),15-PGDH expression was significantly different between two groups (P 〈 0.05).Immunohistochemical results suggested that the expression rate of 15-PGDH in normal esophageal mucosa next to the carcinoma was significantly higher than that in esophageal carcinoma and the difference had a statistically significance (P 〈 0.05).The low expression of 15-PGDH in esophageal carcinoma was found to be unrelated to the histological differentiation and the increased stages (P 〉 0.05).Conclusion In the tissue of normal esophageal mucosa next to the carcinoma,esophageal carcinoma,15-PGDH protein expression is decreased gradually.15-PGDH is correlation to the esophageal canceration and growth.The expression of 15-PGDH is absent or decreased in esophageal carcinoma.The loss or reduction of 15-PGDH may occur in the development of esophageal carcinoma.15-PGDH is an inhibitor of esophageal tumor genesis.
出处 《胃肠病学和肝病学杂志》 CAS 2014年第6期692-695,共4页 Chinese Journal of Gastroenterology and Hepatology
基金 黑龙江省教育厅科学技术研究项目(12511288)
关键词 15-羟基前列腺素脱氢酶 食管癌 淋巴结转移 NAD+-dependent 15-hydroxyprostaglandin dehydrogenase Esophageal carcinoma Lymphatic metastasis
  • 相关文献

参考文献13

  • 1Tong M, Ding Y, Tai HH. Histone deacetylase inhibitors and transfor- ming growth factor-beta induce 15-hydroxyprostaglandin dehydrogenaseexpression in human lung adenocarcinoma cells [ J]. Biochem Pharma- col, 2006, 72(6) : 701-709.
  • 2曹仕琼,魏文杰,熊枝繁.15-PGDH和COX-2在大肠腺癌中的表达[J].胃肠病学和肝病学杂志,2010,19(7):615-618. 被引量:5
  • 3Myung SJ, Rerko RM, Yan M, et al. 15-Hydroxyprostaglandin dehy- drogenase is an in vivo suppressor of colon tumorigenesis [ J ]. Proc Natl Acad Sci U S A, 2006, 103(32) : 12098-12102.
  • 4刘震雄,王景杰,王旭霞,赵曙光,秦明,黄裕新.胃癌组织中15-PGDH与COX-2的表达特征及其临床意义[J].胃肠病学和肝病学杂志,2013,22(4):337-340. 被引量:6
  • 5Liu Z, Wang X, Lu Y, et al. Expression of 15-PGDH is do:nregulat- ed by COX-2 in gastric cancer [J]. Carcinogenesis, 2008, 29(6): 1219-1227.
  • 6Frenkian M, Segond N, Pidoux E, et al. Indomethacin, a cox inhibi- tor, enhances 15-PGDH and decreases human tumoral C ceils prolifera- tion [ J]. Prostaglandins Other Lipid Mediat, 2001, 65 ( 1 ) : 11-20.
  • 7Yan M, Myung S J, Fink SP, et al. 15-Hydroxyprostaglandin dehydro- gcnase inactivation as a mechanism of resistance to celecoxib chemopre- vention of colon tumors [J]. Proc Natl Acad Sci U S A, 2009, 106 (23) : 9409-9413.
  • 8Yan M, Rerko RM, Platzer P, et al. 15-Hydroxyprostaglandin dehy- drogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced sup- pressor of human gastrointestinal cancers [J]. Proc Natl Acad Sci U S A, 2004, 101(50): 17468-17473.
  • 9李美宁,冯燕,解军,常冰梅,张悦红,殷云勤,程牛亮.前列腺素脱氢酶对大肠癌SW480细胞恶性增殖的抑制作用[J].肿瘤防治研究,2008,35(4):236-239. 被引量:3
  • 10Ding Y, Tong M, Litt S, et al. NAD+-linked 15-hydroxypros- taglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer [J]. Carcinogenesis, 2005, 26(1): 65-72.

二级参考文献22

  • 1刘萱,张澍田,于中麟,许彩民,贾继东.环氧合酶-2的信使核糖核酸在人类食管鳞癌中的表达[J].中华消化杂志,2004,24(6):365-366. 被引量:1
  • 2Ding Y, Tong M, Liu S,et al. NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer[J]. Carcinogenesis, 2005,26 ( 1 ) : 65-72.
  • 3Wolf I, OKelly J, Rubinek T, et al. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer [J]. Cancer Res, 2006,66 (15) : 7818-7823.
  • 4Quidville V, Segond N, Lausson S, et al. 15-Hydroxyprostaglandin-dehydrogenase is involved in anti-proliferative effect of non-steroidal anti-inflammatory drugs COX-1 inhibitors on a human medullary thyroid carcinoma cell line[J]. Prostaglandins Other Lipid Mediat, 2006,81 (1-2) : 14-30.
  • 5Storey A, Thomas M, Kalita A, et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer[J]. Nature, 1998, 393(6682) :229-234.
  • 6Muncan V, Sansom OJ, Tertoolen L, et al. Rapid loss of intestinal crypts upon conditional deletion of the Wnt/Tcf-4 target gene c-Myc[J]. Mol Cell Biol,2006,26(22) :8418-8426.
  • 7Yan M, Rerko RM, Platzer P, et al. 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta- induced suppressor of human gastrointestinal cancers[J]. Proc Natl Acad Sci U S A,2004,101(50) :17468-17473.
  • 8Myung SJ, Rerko RM, Yan M, et al. 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis[J]. Proc Natl Acad Sci U S A,2006, 103(32): 12098-12102.
  • 9Cebola I, Peinado MA. Epigenetic deregulation of the COX pathway in cancer [J]. Prog Lipid Res, 2012, 51(4): 301-313.
  • 10Salvado MD, Alfranca A, Haeggstrfim JZ, et al. Prostanoids in tumor angiogenesis: therapeutic intervention beyond COX-2 [ J]. Trends Mol Med, 2012, 18(4) : 233-243.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部